Skip to main content

Table 1 Clinical and pathological characteristics of adjuvant treated SEOC patient samples

From: Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

Sample Age Stage PFS (months) Classification
1100 54 IIIc 5 Resistant
1101 55 IV 5 Resistant
1240 64 III <3 Resistant
1299 53 IIIb 3 Resistant
1413 47 IV <3 Resistant
1587 54 IIIc 0 Resistant
1605 51 IIb 3 Resistant
1703 48 IIIc 6 Resistant
1776 58 IIIc 6 Resistant
D00443 51 III 5 Resistant
1359 62 IIIc 8 Partially Resistant
1680 67 IIc 7 Partially Resistant
1157 61 IIIc 36 Sensitive
1188 58 III 34 Sensitive
1224 22 Sensitive
1296 61 II 39 Sensitive
1304 51 IIIa 26 Sensitive
1308 49 IIIc 25 Sensitive
1351 55 IV No recurrence Sensitive
1355 68 IIa 23 Sensitive
1381 51 IIIa 25 Sensitive
1561 63 IIb 25 Sensitive
1625 54 IIIb 26 Sensitive
1627 52 IIIa No recurrence Sensitive
1706 61 IIIa No recurrence Sensitive
B01183 79 IIIc 22 Sensitive
B01360 54 IIIc 19 Sensitive
B01440 53 IIIc 20 Sensitive